跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,604 条关于
“DMO”
全部
1,604
临床试验
989
药物
264
机构
85
资讯
266
2年前
Bayer's High-Dose Eylea 8mg (Aflibercept) Accepted for Review by China's NMPA Following UK Approval
9个月前
Agora Open Science Trust Selects M4K2009 as Lead Candidate for Rare Pediatric Brain Cancer Treatment
8个月前
4Moving Biotech Secures FDA IND Clearance for First-in-Class Intra-Articular GLP-1 Agonist in Osteoarthritis
去年
TG-C Shows Promise as First Disease-Modifying Therapy for Knee Osteoarthritis with 15-Year Safety Data
去年
BlueWind Medical's Revi® System Shows Sustained Efficacy for Urinary Incontinence at Two-Year Mark
去年
OrthoTrophix Launches Phase 2b Trial of TPX-100 for Knee Osteoarthritis with Disease-Modifying Potential
去年
Synchron Advances Toward Pivotal Trial for Stentrode BCI After Promising Command Study Results
2个月前
Applied Biologics Manufactures First Research Construct for Disease-Modifying Osteoarthritis Gene Therapy
去年
Health Canada Authorizes 4Moving Biotech's Phase 2a Trial for Novel Knee Osteoarthritis Treatment
去年
4Moving Biotech Initiates Phase 2a Trial of First-in-Class GLP-1 Therapy for Knee Osteoarthritis
第 1 页,共 27 页
上一页
下一页